Methotrexate – Genotoxic and teratogenic for medical staff of oncology wards?

Methotrexate (MTX) is one of the most widely used cytostatic drugs belonging to the folic acid antagonists. It is a substance non-classified as a carcinogen in the European Union and by the International Agency for Research on Cancer (IARC) as there is no evidence of its carcinogenicity to humans an...

Full description

Bibliographic Details
Main Author: Małgorzata Kupczewska-Dobecka
Format: Article
Language:English
Published: Nofer Institute of Occupational Medicine 2015-06-01
Series:Medycyna Pracy
Subjects:
Online Access:http://medpr.imp.lodz.pl/Metotreksat-genotoksyczny-i-teratogenny-dla-personelu-medycznego-onkologicznych-oddzialow-szpitalnych-,2410,0,2.html
_version_ 1811259259521859584
author Małgorzata Kupczewska-Dobecka
author_facet Małgorzata Kupczewska-Dobecka
author_sort Małgorzata Kupczewska-Dobecka
collection DOAJ
description Methotrexate (MTX) is one of the most widely used cytostatic drugs belonging to the folic acid antagonists. It is a substance non-classified as a carcinogen in the European Union and by the International Agency for Research on Cancer (IARC) as there is no evidence of its carcinogenicity to humans and animals. Nevertheless, MTX has been placed on the list of dangerous drugs used in chemotherapy, mainly due to genotoxic and teratogenic effects, causing developmental toxicity and reproductive toxicity. Methotrexate was determined in the hospital ward air during the preparation of a medicament at a level of 0.3 mg/m3, as well as on protective gloves and preparatory room surfaces. In most research projects MTX was identified in the urine of health care workers, pharmacists and nursing staff. The highest cumulative concentration of MTX in 112 urine samples was 1416 mg in workers preparing infusions for patients. Studies carried out in pharmacies revealed the presence of MTX in 60% of tests, and the maximum concentration of 15 ng/cm2 surface of the tray to count tablets. Legal exposure limit values for MTX in the work environment have not yet been established. Occupational exposure limits have been established by some manufacturers at the level of 0.0003–0.0025 mg/m3. There is an urgent need to establish normative values. It should also be emphasized that MTX is absorbed through the skin, which may significantly increase the exposure and measuring its concentration in the work environment may not be sufficient to estimate the actual exposure. Med. Pr. 2015;66(2):265–275
first_indexed 2024-04-12T18:27:47Z
format Article
id doaj.art-f302585583504d1ebdadb2f80f503755
institution Directory Open Access Journal
issn 0465-5893
2353-1339
language English
last_indexed 2024-04-12T18:27:47Z
publishDate 2015-06-01
publisher Nofer Institute of Occupational Medicine
record_format Article
series Medycyna Pracy
spelling doaj.art-f302585583504d1ebdadb2f80f5037552022-12-22T03:21:10ZengNofer Institute of Occupational MedicineMedycyna Pracy0465-58932353-13392015-06-0166226527510.13075/mp.5893.00081Methotrexate – Genotoxic and teratogenic for medical staff of oncology wards?Małgorzata Kupczewska-DobeckaMethotrexate (MTX) is one of the most widely used cytostatic drugs belonging to the folic acid antagonists. It is a substance non-classified as a carcinogen in the European Union and by the International Agency for Research on Cancer (IARC) as there is no evidence of its carcinogenicity to humans and animals. Nevertheless, MTX has been placed on the list of dangerous drugs used in chemotherapy, mainly due to genotoxic and teratogenic effects, causing developmental toxicity and reproductive toxicity. Methotrexate was determined in the hospital ward air during the preparation of a medicament at a level of 0.3 mg/m3, as well as on protective gloves and preparatory room surfaces. In most research projects MTX was identified in the urine of health care workers, pharmacists and nursing staff. The highest cumulative concentration of MTX in 112 urine samples was 1416 mg in workers preparing infusions for patients. Studies carried out in pharmacies revealed the presence of MTX in 60% of tests, and the maximum concentration of 15 ng/cm2 surface of the tray to count tablets. Legal exposure limit values for MTX in the work environment have not yet been established. Occupational exposure limits have been established by some manufacturers at the level of 0.0003–0.0025 mg/m3. There is an urgent need to establish normative values. It should also be emphasized that MTX is absorbed through the skin, which may significantly increase the exposure and measuring its concentration in the work environment may not be sufficient to estimate the actual exposure. Med. Pr. 2015;66(2):265–275http://medpr.imp.lodz.pl/Metotreksat-genotoksyczny-i-teratogenny-dla-personelu-medycznego-onkologicznych-oddzialow-szpitalnych-,2410,0,2.htmlmethotrexateprofessional exposureantineoplastic drugs
spellingShingle Małgorzata Kupczewska-Dobecka
Methotrexate – Genotoxic and teratogenic for medical staff of oncology wards?
Medycyna Pracy
methotrexate
professional exposure
antineoplastic drugs
title Methotrexate – Genotoxic and teratogenic for medical staff of oncology wards?
title_full Methotrexate – Genotoxic and teratogenic for medical staff of oncology wards?
title_fullStr Methotrexate – Genotoxic and teratogenic for medical staff of oncology wards?
title_full_unstemmed Methotrexate – Genotoxic and teratogenic for medical staff of oncology wards?
title_short Methotrexate – Genotoxic and teratogenic for medical staff of oncology wards?
title_sort methotrexate genotoxic and teratogenic for medical staff of oncology wards
topic methotrexate
professional exposure
antineoplastic drugs
url http://medpr.imp.lodz.pl/Metotreksat-genotoksyczny-i-teratogenny-dla-personelu-medycznego-onkologicznych-oddzialow-szpitalnych-,2410,0,2.html
work_keys_str_mv AT małgorzatakupczewskadobecka methotrexategenotoxicandteratogenicformedicalstaffofoncologywards